Danaher Corporation $DHR Shares Acquired by Natixis Advisors LLC

Natixis Advisors LLC lifted its holdings in shares of Danaher Corporation (NYSE:DHR) by 22.7% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 765,616 shares of the conglomerate’s stock after buying an additional 141,495 shares during the period. Natixis Advisors LLC’s holdings in Danaher were worth $175,265,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. JPL Wealth Management LLC acquired a new position in shares of Danaher during the 3rd quarter worth approximately $25,000. Elevated Capital Advisors LLC acquired a new position in shares of Danaher during the 4th quarter worth approximately $26,000. WFA of San Diego LLC acquired a new position in shares of Danaher during the 2nd quarter worth approximately $26,000. ANTIPODES PARTNERS Ltd acquired a new position in shares of Danaher during the 3rd quarter worth approximately $27,000. Finally, Financial Life Planners acquired a new position in shares of Danaher during the 3rd quarter worth approximately $32,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts recently commented on DHR shares. Citigroup started coverage on Danaher in a research note on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price objective for the company. TD Cowen reduced their price objective on Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Rothschild & Co Redburn set a $205.00 price objective on Danaher in a research note on Friday, April 17th. UBS Group reduced their price objective on Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Finally, Morgan Stanley reduced their price objective on Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. Nineteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $238.24.

Danaher Stock Down 1.4%

Shares of DHR opened at $180.07 on Tuesday. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a market capitalization of $127.45 billion, a PE ratio of 34.83, a price-to-earnings-growth ratio of 2.44 and a beta of 0.81. The stock has a fifty day simple moving average of $181.91 and a two-hundred day simple moving average of $207.20. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last issued its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. During the same period last year, the company earned $1.88 EPS. The company’s revenue for the quarter was up 3.7% on a year-over-year basis. As a group, equities analysts forecast that Danaher Corporation will post 8.43 EPS for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. Danaher’s dividend payout ratio is currently 30.95%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.